• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过脂质体实现局部药物递送以克服障碍。

Overcoming barriers by local drug delivery with liposomes.

机构信息

Laboratory of Pharmaceutical Technology, Dept. of Pharmacy, School of Health Sciences, University of Patras, 26504 Rio Patras, Greece; Institute of Chemical Engineering Sciences, Foundation for Research and Technology Hellas (FORTH/ICES), 26504 Rio Patras, Greece.

Laboratory of Pharmaceutical Technology, Dept. of Pharmacy, School of Health Sciences, University of Patras, 26504 Rio Patras, Greece.

出版信息

Adv Drug Deliv Rev. 2021 Jul;174:53-86. doi: 10.1016/j.addr.2021.01.019. Epub 2021 Feb 2.

DOI:10.1016/j.addr.2021.01.019
PMID:33539852
Abstract

Localized or topical administration of drugs may be considered as a potential approach for overcoming the problems caused by the various biological barriers encountered in drug delivery. The combination of using localized administration routes and delivering drugs in nanoparticulate formulations, such as liposomes, may have additional advantages. Such advantages include prolonged retention of high drug loads at the site of action and controlled release of the drug, ensuring prolonged therapeutic effect; decreased potential for side-effects and toxicity (due to the high topical concentrations of drugs); and increased protection of drugs from possible harsh environments at the site of action. The use of targeted liposomal formulations may further potentiate any acquired therapeutic advantages. In this review we present the most advanced cases of localized delivery of liposomal formulations of drugs, which have been investigated pre-clinically and clinically in the last ten years, together with the reported therapeutic advantages, in each case.

摘要

局部或局部给药可能被认为是克服药物输送中遇到的各种生物屏障所带来的问题的一种潜在方法。将局部给药途径与纳米颗粒制剂(如脂质体)联合使用可能具有额外的优势。这些优势包括在作用部位长时间保持高药物负荷和药物的控制释放,从而确保长期的治疗效果;降低药物的潜在副作用和毒性(由于药物的高局部浓度);以及增加对作用部位可能恶劣环境中药物的保护。靶向脂质体制剂的使用可能进一步增强任何获得的治疗优势。在这篇综述中,我们介绍了过去十年中在临床前和临床上研究过的最先进的局部递药脂质体制剂的案例,以及在每种情况下报告的治疗优势。

相似文献

1
Overcoming barriers by local drug delivery with liposomes.通过脂质体实现局部药物递送以克服障碍。
Adv Drug Deliv Rev. 2021 Jul;174:53-86. doi: 10.1016/j.addr.2021.01.019. Epub 2021 Feb 2.
2
Elastic liposomes as novel carriers: recent advances in drug delivery.弹性脂质体作为新型载体:药物递送的最新进展
Int J Nanomedicine. 2017 Jul 17;12:5087-5108. doi: 10.2147/IJN.S138267. eCollection 2017.
3
Topical nanocarriers for management of Rheumatoid Arthritis: A review.标题:用于治疗类风湿关节炎的局部纳米载体:综述。
Biomed Pharmacother. 2021 Sep;141:111880. doi: 10.1016/j.biopha.2021.111880. Epub 2021 Jul 14.
4
Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems.使用颗粒系统进行疫苗鼻内递送的药学方面。
J Pharm Sci. 2009 Mar;98(3):812-43. doi: 10.1002/jps.21493.
5
Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.鼻腔内纳米颗粒给药系统作为药物传递的替代途径。
Curr Med Chem. 2019;26(35):6459-6492. doi: 10.2174/0929867326666190827151741.
6
Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.软物质纳米载体介导的蛋白质和肽的经皮递药的最新进展。
Biotechnol Adv. 2015 Nov 1;33(6 Pt 3):1355-69. doi: 10.1016/j.biotechadv.2015.01.010. Epub 2015 Feb 14.
7
Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.负载补骨脂素的脂质体纳米载体可改善皮肤渗透性并提高外用补骨脂素紫外线A光化学疗法治疗银屑病的疗效。
Eur J Pharm Sci. 2017 Jan 1;96:515-529. doi: 10.1016/j.ejps.2016.10.025. Epub 2016 Oct 21.
8
Liposomal drug delivery systems: from concept to clinical applications.脂质体药物递送系统:从概念到临床应用。
Adv Drug Deliv Rev. 2013 Jan;65(1):36-48. doi: 10.1016/j.addr.2012.09.037. Epub 2012 Oct 1.
9
Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System.使用纳米颗粒载体系统进行大分子非侵入性递送的最新进展
Curr Pharm Des. 2017;23(3):440-453. doi: 10.2174/1381612822666161026163201.
10
Challenges in development of targeted liposomal therapeutics.靶向脂质体治疗药物开发面临的挑战。
AAPS J. 2012 Jun;14(2):303-15. doi: 10.1208/s12248-012-9330-0. Epub 2012 Mar 14.

引用本文的文献

1
Hydrogel-Based Microspheres for Intra-Articular Osteoarthritis Therapy: Multifunctional Carriers for Drug Delivery and Cartilage Repair: A Comprehensive Review.用于关节内骨关节炎治疗的水凝胶基微球:用于药物递送和软骨修复的多功能载体:综述
Int J Nanomedicine. 2025 Sep 4;20:10795-10813. doi: 10.2147/IJN.S538490. eCollection 2025.
2
Synergistic Ferroptosis-Immunotherapy Nanoplatforms: Multidimensional Engineering for Tumor Microenvironment Remodeling and Therapeutic Optimization.协同铁死亡-免疫疗法纳米平台:用于肿瘤微环境重塑和治疗优化的多维工程
Nanomicro Lett. 2025 Sep 2;18(1):56. doi: 10.1007/s40820-025-01862-6.
3
Innovative nanocarriers: Synthetic and biomimetic strategies for enhanced drug delivery.
创新纳米载体:用于增强药物递送的合成与仿生策略
Mater Today Bio. 2025 Aug 8;34:102180. doi: 10.1016/j.mtbio.2025.102180. eCollection 2025 Oct.
4
Transdermal delivery of CRISPR/Cas9-mediated melanoma gene therapy via polyamines-modified thermosensitive hydrogels.通过多胺修饰的热敏水凝胶进行CRISPR/Cas9介导的黑色素瘤基因治疗的经皮递送
J Nanobiotechnology. 2025 Jun 13;23(1):441. doi: 10.1186/s12951-025-03523-7.
5
Vitamin D and Inhibition of Melanogenesis: Examination of Liposomal Vitamin D Nanocarrier Anti-Melanogenesis Activity on B16 F10 Cell Line.维生素D与黑色素生成抑制:脂质体维生素D纳米载体对B16 F10细胞系抗黑色素生成活性的研究
Food Sci Nutr. 2025 May 19;13(5):e70302. doi: 10.1002/fsn3.70302. eCollection 2025 May.
6
Innovative PEGylated chitosan nanocarriers for co-delivery of doxorubicin and CpG in breast cancer therapy: Preparation, characterization, and immunotherapeutic potential.用于乳腺癌治疗中阿霉素和CpG共递送的新型聚乙二醇化壳聚糖纳米载体:制备、表征及免疫治疗潜力
Med Oncol. 2025 Apr 23;42(5):176. doi: 10.1007/s12032-025-02714-4.
7
Cholesterol-Rich Antibiotic-Loaded Liposomes as Efficient Antimicrobial Therapeutics.富含胆固醇的载抗生素脂质体作为高效抗菌疗法
Int J Nanomedicine. 2025 Apr 17;20:4943-4965. doi: 10.2147/IJN.S513553. eCollection 2025.
8
Targeting respiratory virus-induced reactive oxygen species in airways diseases.针对呼吸道病毒诱导的气道疾病中的活性氧物质
Eur Respir Rev. 2025 Apr 16;34(176). doi: 10.1183/16000617.0169-2024. Print 2025 Apr.
9
High-Load Core@Shell Nanocarriers with Irinotecan and 5-Fluorouracil for Combination Chemotherapy in Colorectal Cancer.负载伊立替康和5-氟尿嘧啶的高负载核壳纳米载体用于结直肠癌的联合化疗
Small Sci. 2024 Aug 19;4(11):2400196. doi: 10.1002/smsc.202400196. eCollection 2024 Nov.
10
Folate receptor-targeted pH-sensitive liposomes loaded with TGX-221 against prostate cancer by inhibiting PI3K/110β signaling.载有TGX-221的叶酸受体靶向pH敏感脂质体通过抑制PI3K/110β信号传导来对抗前列腺癌。
Nanoscale Adv. 2025 Mar 14. doi: 10.1039/d5na00009b.